期刊文献+

糖尿病与冠状动脉微循环障碍的研究进展 被引量:11

Research Progress in the Relationship between Coronary Microvascular Dysfunction and Diabetic Mellitus
下载PDF
导出
摘要 糖尿病患者无论是否合并冠状动脉狭窄均常存在冠状动脉微循环障碍(CMD)。CMD可加重糖尿病患者的心肌缺血,增加糖尿病患者不良心血管事件的发生风险。糖尿病患者长期高血糖状态刺激介导内皮损害、氧化应激、炎症反应和血小板功能异常,与糖尿病合并CMD的发生、发展密切相关。侵入性和非侵入性的影像学方法可用于发现CMD,但不能显示其内在的发病机制。针对CMD相关发病机制的治疗方案也尚未经临床试验确证其疗效。探究糖尿病与CMD之间的关系有望为临床诊疗CMD提供新思路。 Coronary microvascular dysfunction(CMD)is often found in diabetes mellitus patients no matter whether they are complicated with concomitant coronary artery stenosis.CMD leads to more severe myocardial ischemia and increases the risk of adverse cardiovascular events in diabetic mellitus patients.Long-term hyperglycemia causes endothelial damage,oxidative stress,inflammatory response and abnormal platelet function,which are closely related to the occurrence and deve-lopment of CMD in diabetic mellitus.Invasive and noninvasive imaging methods are used to detect CMD,but cannot reveal its pathogenesis.The treatment of CMD aiming at its pathogenesis has not been confirmed its efficacy by clinical trials yet.Therefore,exploration of the relationship between diabetic mellitus and CMD may provide new clinical ideas for the diagnosis and treatment of CMD.
作者 唐莉莉 姚道阔 王萍 陈晖 TANG Lili;YAO Daokuo;WANG Ping;CHEN Hui(Department of Heart Center,Beijing Friendship Hospital,Capital Medical University,Beijing 100050,China)
出处 《医学综述》 2018年第13期2497-2501,共5页 Medical Recapitulate
基金 首都医科大学基础-临床科研合作基金(16JL19 17JL39)
关键词 糖尿病 冠状动脉微循环障碍 发病机制 诊断方法 干预措施 Diabetes mellitus Coronary microvascular dysfunction Pathogenesis Assessment methods Interventions
  • 相关文献

参考文献2

二级参考文献149

  • 1Li Lin.RAGE on the Toll Road?[J].Cellular & Molecular Immunology,2006,3(5):351-358. 被引量:12
  • 2TTimarci.
  • 3Wautier MP;Chappey O;Corda S;Stern DM,Schmidt AM,Wautier JL.Activation of NADPH oxidase by AGE links oxidant stress to altered gene expression via RAGE,2001.
  • 4Xie J,Reverdatto S,Frolov A,Hoffmann R,Burz DS,Shekhtman A.Structural basis for pattern recognition by the receptor for advanced glycation end products (RAGE). Journal of Biological Chemistry . 2008
  • 5Hudson BI,Carter AM,Harja E,Kalea AZ,Arriero M,Yang H,Grant PJ,Schmidt AM.Identification,classification,and expression of RAGE gene splice variants. The FASEB Journal . 2008
  • 6Taguchi A,Blood DC,del Toro G,Canet A,Lee DC,Qu W,Tanji N,Lu Y,Lalla E,Fu C,Hofmann MA,Kislinger T,Ingram M,Lu A,Tanaka H,Hori O,Ogawa S,Stern DM,Schmidt AM.Blockade of RAGE-amphoterin signalling suppresses tumour growth and metastases. Nature . 2000
  • 7Sugaya K,Fukagawa T,Matsumoto K,et al.Three genes in the human MHC class III region near the junction with the class II: gene for receptor of advanced glycosylation end products, PBX2 homeobox gene and a notch homolog, human counterpart of mouse mammary tumor gene int-3. Genomics . 1994
  • 8Schmidt A M,Yan S D,Yan S F,et al.The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses. The Journal of Clinical Investigation . 2001
  • 9Neeper M,Schmidt AM,Brett J,et al.Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins. Journal of Biological Chemistry . 1992
  • 10Kislinger T,Fu C,Huber B,et al.N(epsilon)-(carboxymethyl)lysine adducts of proteins are ligands for receptor for advanced glycation end products that activate cell signaling pathways and modulate gene expression. Journal of Biological Chemistry . 1999

共引文献61

同被引文献143

引证文献11

二级引证文献60

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部